Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
- 1 January 2002
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 25 (12) , 885-892
- https://doi.org/10.2165/00002018-200225120-00006
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- FDA Labeling System for Drugs in PregnancyAnnals of Pharmacotherapy, 2001
- Perception of teratogenic risk of common medicinesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- Prescription of drugs during pregnancy in FranceThe Lancet, 2000
- Prescribing during pregnancy and lactation with reference to the Swedish classification system, A population‐based study among Danish womenActa Obstetricia et Gynecologica Scandinavica, 1999
- Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.1997
- The Physicians' Desk Reference. Problems and possible improvements.1996
- Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimesterAmerican Journal of Obstetrics and Gynecology, 1989
- Physicians' Sources of Information about Teratogenic Effects of DrugsDrug Information Journal, 1982
- Pregnancy labeling.1979